Resident intimal dendritic cells and the initiation of atherosclerosis

Current Opinion in Lipidology

Volumn 21, Issue 5, 2010, Pages 397-403

  Cybulsky, Myron I ^a,b   Jongstra Bilen, Jenny ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Department of Brain Sciences   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

dendritic cells; endothelium; gene expression; hemodynamics; monocytes

Indexed keywords

LIPID;

AORTA; ARTERY INTIMA; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; DENDRITIC CELL; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; FOAM CELL; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HEMODYNAMICS; HYPERCHOLESTEROLEMIA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; AORTA; ATHEROSCLEROSIS; DENDRITIC CELLS; GENETIC PREDISPOSITION TO DISEASE; HEMORHEOLOGY; HUMANS; TUNICA INTIMA;

EID: 77957588378     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32833ded96     Document Type: Review

References (62)

1. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009; 10:53-62.
2. Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85:199-207.
3. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195-2224.
4. Hajra L, Evans AI, Chen M, et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A 2000; 97:9052-9057.
5. Jongstra-Bilen J, Haidari M, Zhu SN, et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006; 203:2073-2083.
6. Paulson KE, Zhu SN, Chen M, et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 2010; 106:383-390.
7. Passerini AG, Polacek DC, Shi C, et al. Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci U S A 2004; 101:2482-2487.
8. Won D, Zhu SN, Chen M, et al. Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow. Am J Pathol 2007; 171:1691-1704.
9. Parmar KM, Larman HB, Dai G, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006; 116:49-58.
10. Wight TN, Merrilees MJ. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004; 94:1158-1167.
11. Orr AW, Sanders JM, Bevard M, et al. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol 2005; 169:191-202.
12. Zhu SN, Chen M, Jongstra-Bilen J, Cybulsky MI. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J Exp Med 2009; 206: 2141-2149.
13. Malinauskas RA, Herrmann RA, Truskey GA. The distribution of intimal white blood cells in the normal rabbit aorta. Atherosclerosis 1995; 115:147-163.
14. Millonig G, Schwentner C, Mueller P, et al. The vascular-associated lymphoid tissue: a new site of local immunity. Curr Opin Lipidol 2001; 12:547-553.
15. Millonig G, Niederegger H, Rabl W, et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001; 21:503-508.
16. Bobryshev YV, Lord RS. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. Arch Histol Cytol 1995; 58:307-322.
17. Liu P, Yu YR, Spencer JA, et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 2008; 28:243-250.
18. Mullick AE, Soldau K, Kiosses WB, et al. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 2008; 205:373-383.
19. Choi JH, Do Y, Cheong C, et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 2009; 206:497-505.
20. Smith JD, James D, Dansky HM, et al. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23:117-122.
21. Tian J, Pei H, James JC, et al. Circulating adhesion molecules in apoEdeficient mouse strains with different atherosclerosis susceptibility. Biochem Biophys Res Commun 2005; 329:1102-1107.
22. Shi W, Haberland ME, Jien ML, et al. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 2000; 102:75-81.
23. Shi W, Wang NJ, Shih DM, et al. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res 2000; 86:1078-1084.
24. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001; 69:11-20.
25. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19:71-82.
26. Sunderkotter C, Nikolic T, Dillon MJ, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172:4410-4417.
27. Ziegler-Heitbrock L. The CD14 CD16 blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-592.
28. Auffray C, Fogg D,GarfaM, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317:666-670.
29. Mosig S, Rennert K, Krause S, et al. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14 CD16 monocytes in detoxification of oxidized LDL. FASEB J 2009; 23:866-874.
30. Ingersoll MA, Spanbroek R, Lottaz C, et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010; 115:e10-e19.
31. Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107:1255-1262.
32. Dansky HM, Barlow CB, Lominska C, et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 2001; 21:1662-1667.
33. Nakashima Y, Raines EW, Plump AS, et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoEdeficient mouse. Arterioscler Thromb Vasc Biol 1998; 18:842-851.
34. Nageh MF, Sandberg ET, Marotti KR, et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997; 17:1517-1520.
35. Wu H, Gower RM, Wang H, et al. Functional role of CD11c monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009; 119:2708-2717.
36. Sadhu C, Ting HJ, Lipsky B, et al. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. J Leukoc Biol 2007; 81:1395-1403.
37. Cybulsky MI, Hegele RA. The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J Clin Invest 2003; 111:1118-1120.
38. Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1/fractalkine expression in endothelial cells. J Atheroscler Thromb 2004; 11:15-21.
39. Ancuta P, Rao R, Moses A, et al. Fractalkine preferentially mediates arrest and migration of CD16 monocytes. J Exp Med 2003; 197:1701-1707.
40. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009; 113:963-972.
41. Galkina E, Kadl A, Sanders J, et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006; 203:1273-1282.
42. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
43. Niessner A, Weyand CM. Dendritic cells in atherosclerotic disease. Clin Immunol 2010; 134:25-32.
44. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
45. Bobryshev YV. Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 2000; 11:511-517.
46. Bogunovic M, Ginhoux F, Helft J, et al. Origin of the lamina propria dendritic cell network. Immunity 2009; 31:513-525.
47. Varol C, Vallon-Eberhard A, Elinav E, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009; 31:502-512.
48. Ohteki T, Tada H, Ishida K, et al. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J Exp Med 2006; 203:2329-2338.
49. Scholz J, Lukacs-Kornek V, Engel DR, et al. Renal dendritic cells stimulate IL-production and attenuate nephrotoxic nephritis. J Am Soc Nephrol 2008; 19:527-537.
50. Van Rijt LS, Jung S, Kleinjan A, et al. In vivo depletion of lung CD11c dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201:981-991.
51. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c() dendritic cells abrogates priming of CD8() T cells by exogenous cell-associated antigens. Immunity 2002; 17:211-220.
52. Kruth HS, Jones NL, Huang W, et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem 2005; 280:2352-2360.
53. Horiuchi S, Sakamoto Y, Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 2003; 25:283-292.
54. Nickel T, Schmauss D, Hanssen H, et al. oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 2009; 205:442-450.
55. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15:551-561.
56. Skalen K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002; 417:750-754.
57. Sertl K, Takemura T, Tschachler E, et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986; 163:436-451.
58. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991; 173:1345-1356.
59. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2:361-367.
60. Cybulsky MI, Won D, Haidari M. Leukocyte recruitment to atherosclerotic lesions. Can J Cardiol 2004; 20 (Suppl B):24B-28B.
61. Gautier EL, Jakubzick C, Randolph GJ. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:1412-1418.
62. Stoneman V, Braganza D, Figg N, et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007; 100:884-893.